These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 35705514)
1. Human seasonal coronavirus neutralization and COVID-19 severity. Wells DA; Cantoni D; Mayora-Neto M; Genova CD; Sampson A; Ferrari M; Carnell G; Nadesalingam A; Smith P; Chan A; Raddi G; Castillo-Olivares J; Baxendale H; Temperton N; Heeney JL J Med Virol; 2022 Oct; 94(10):4820-4829. PubMed ID: 35705514 [TBL] [Abstract][Full Text] [Related]
2. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses. Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775 [TBL] [Abstract][Full Text] [Related]
3. Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses. Sampson AT; Heeney J; Cantoni D; Ferrari M; Sans MS; George C; Di Genova C; Mayora Neto M; Einhauser S; Asbach B; Wagner R; Baxendale H; Temperton N; Carnell G Viruses; 2021 Aug; 13(8):. PubMed ID: 34452443 [TBL] [Abstract][Full Text] [Related]
4. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination? Asamoah-Boaheng M; Grunau B; Karim ME; Jassem AN; Bolster J; Marquez AC; Scheuermeyer FX; Goldfarb DM Front Immunol; 2022; 13():954093. PubMed ID: 36159791 [TBL] [Abstract][Full Text] [Related]
5. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers. Jackson-Thompson BM; Goguet E; Laing ED; Olsen CH; Pollett S; Hollis-Perry KM; Maiolatesi SE; Illinik L; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Davies J; Ortega O; Parmelee E; Lindrose AR; Moser M; Graydon E; Letizia AG; Duplessis CA; Ganesan A; Pratt KP; Malloy AM; Scott DW; Anderson SK; Snow AL; Dalgard CL; Powers JH; Tribble D; Burgess TH; Broder CC; Mitre E BMC Infect Dis; 2021 Jun; 21(1):544. PubMed ID: 34107889 [TBL] [Abstract][Full Text] [Related]
6. Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2. Galipeau Y; Siragam V; Laroche G; Marion E; Greig M; McGuinty M; Booth RA; Durocher Y; Cuperlovic-Culf M; Bennett SAL; Crawley AM; Giguère PM; Cooper C; Langlois MA EBioMedicine; 2021 Dec; 74():103700. PubMed ID: 34861490 [TBL] [Abstract][Full Text] [Related]
7. Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography. Wang J; Li D; Zhou Q; Wiltse A; Zand MS Front Immunol; 2021; 12():696370. PubMed ID: 34386006 [TBL] [Abstract][Full Text] [Related]
8. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples. Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of four endemic human coronaviruses and, reactivity and neutralization capability against SARS-CoV-2 among children in the Philippines. Sayama Y; Okamoto M; Saito M; Saito-Obata M; Tamaki R; Joboco CD; Lupisan S; Oshitani H Sci Rep; 2023 Feb; 13(1):2310. PubMed ID: 36759702 [TBL] [Abstract][Full Text] [Related]
10. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals. Adami FL; de Castro MV; Almeida BDS; Daher IP; Yamamoto MM; Souza Santos K; Zatz M; Naslavsky MS; Rosa DS; Cunha-Neto E; de Oliveira VL; Kalil J; Boscardin SB Front Immunol; 2024; 15():1396603. PubMed ID: 38846944 [TBL] [Abstract][Full Text] [Related]
11. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study. Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013 [TBL] [Abstract][Full Text] [Related]
12. High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines. Joseph JO; Ylade M; Daag JV; Aogo R; Crisostomo MV; Mpingabo P; Premkumar L; Deen J; Katzelnick LC BMC Infect Dis; 2024 Sep; 24(1):1042. PubMed ID: 39333882 [TBL] [Abstract][Full Text] [Related]
13. An overview on the seven pathogenic human coronaviruses. Kesheh MM; Hosseini P; Soltani S; Zandi M Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073 [TBL] [Abstract][Full Text] [Related]
14. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study. Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431 [TBL] [Abstract][Full Text] [Related]
15. Seasonal human coronaviruses OC43, 229E, and NL63 induce cell surface modulation of entry receptors and display host cell-specific viral replication kinetics. Siragam V; Maltseva M; Castonguay N; Galipeau Y; Srinivasan MM; Soto JH; Dankar S; Langlois M-A Microbiol Spectr; 2024 Jul; 12(7):e0422023. PubMed ID: 38864599 [TBL] [Abstract][Full Text] [Related]
16. Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France. Woudenberg T; Pelleau S; Anna F; Attia M; Donnadieu F; Gravet A; Lohmann C; Seraphin H; Guiheneuf R; Delamare C; Stefic K; Marlet J; Brochot E; Castelain S; Augereau O; Sibilia J; Dubos F; Meddour D; Guen CG; Coste-Burel M; Imbert-Marcille BM; Chauvire-Drouard A; Schweitzer C; Gatin A; Lomazzi S; Joulié A; Haas H; Cantais A; Bertholon F; Chinazzo-Vigouroux MF; Abdallah MS; Arowas L; Charneau P; Hoen B; Demeret C; Werf SV; Fontanet A; White M EBioMedicine; 2021 Aug; 70():103495. PubMed ID: 34304047 [TBL] [Abstract][Full Text] [Related]
17. Humoral response to SARS-CoV-2 and seasonal coronaviruses in COVID-19 patients. Adams O; Andrée M; Rabl D; Ostermann PN; Schaal H; Lehnert E; Ackerstaff S; Müller L; Fischer JC J Med Virol; 2022 Mar; 94(3):1096-1103. PubMed ID: 34716706 [TBL] [Abstract][Full Text] [Related]
18. Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity. Stanley AM; Aksyuk AA; Wilkins D; Green JA; Lan D; Shoemaker K; Tieu HV; Sobieszczyk ME; Falsey AR; Kelly EJ Front Immunol; 2024; 15():1401728. PubMed ID: 38827749 [TBL] [Abstract][Full Text] [Related]
19. Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2. Liu D; Chen C; Chen D; Zhu A; Li F; Zhuang Z; Mok CKP; Dai J; Li X; Jin Y; Chen Z; Sun J; Wang Y; Li Y; Zhang Y; Wen L; Zhang Z; Zhuo J; Wang J; Ran W; Wang D; Zhang S; Tang Y; Li S; Lai X; Wei P; Yuan J; Chen F; Huang S; Sun F; Qian Z; Tan W; Zhao J; Peiris M; Zhao J Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2202820120. PubMed ID: 36652473 [TBL] [Abstract][Full Text] [Related]
20. Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor. Weil T; Lawrenz J; Seidel A; Münch J; Müller JA Antiviral Res; 2022 Jul; 203():105343. PubMed ID: 35598779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]